The University of Chicago Header Logo

Connection

Hedy Kindler to Imatinib Mesylate

This is a "connection" page, showing publications Hedy Kindler has written about Imatinib Mesylate.
Connection Strength

0.080
  1. Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma. Lung Cancer. 2004 Aug; 45 Suppl 1:S125-7.
    View in: PubMed
    Score: 0.061
  2. A review of resistance patterns and phenotypic changes in gastrointestinal stromal tumors following imatinib mesylate therapy. J Gastrointest Surg. 2007 Jun; 11(6):758-66.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.